Literature DB >> 23495036

Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinoma.

Qing Kay Li1, Summer L Nugent, Joely Straseski, David Cooper, Stefan Riedel, Frederic B Askin, Lori J Sokoll.   

Abstract

BACKGROUND: Ultrasound-guided fine-needle aspiration (US-FNA) cytology is a commonly used method in the surveillance of suspicious lymph nodes (LNs) in patients with papillary thyroid carcinoma (PTC). The measurement of thyroglobulin (Tg) levels in LNs during FNA has been suggested to improve the diagnosis. In the current study, the use of US-FNA-Tg in LNs that were suspicious for metastatic PTC was investigated.
METHODS: A total of 208 cases from the Johns Hopkins Hospital with both US-guided FNA cytology and US-FNA-Tg measurements were included; 60 cases had follow-up surgeries performed. Tg levels were correlated with cytological and histological diagnoses.
RESULTS: Of 35 cases of cytologically diagnosed metastatic PTC, 34 were confirmed by surgery. The median US-FNA-Tg concentration was 4232.7 ng/mL, whereas in 112 benign LNs the median Tg concentration was < 0.2 ng/mL (P < .0001). Receiver operating characteristic analysis (area under the curve, 0.949) demonstrated a sensitivity of 97% and a specificity of 81% at the Tg detection limit (<0.2 ng/mL), whereas cutoff values of 9.6 ng/mL to 100 ng/mL resulted in a sensitivity of 76% and a specificity of 98%. Of 15 cases with a cytological diagnosis of "suspicious for PTC," 9 cases had markedly elevated Tg levels detected on FNA. Seven of these 9 cases had follow-up surgeries confirming the diagnosis of PTC. Of 29 cases with a "nondiagnostic" cytology, 7 had markedly elevated Tg levels on FNA, with a median of 1305.5 ng/mL, and were confirmed to be metastatic PTC at surgery.
CONCLUSIONS: US-FNA-Tg demonstrated a strong negative predictive value (93%-99%). It may be particularly useful for difficult cases. However, standardization of the sample collection is still needed to further improve the accuracy of the approach.
Copyright © 2013 American Cancer Society.

Entities:  

Keywords:  cytology; fine-needle aspiration; fine-needle aspiration thyroglobulin level; lymph node metastasis; papillary thyroid carcinoma

Mesh:

Substances:

Year:  2013        PMID: 23495036     DOI: 10.1002/cncy.21285

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  5 in total

1.  Percutaneous CT-guided needle biopsies of musculoskeletal tumors: a 5-year analysis of non-diagnostic biopsies.

Authors:  Connie Y Chang; Ambrose J Huang; Miriam A Bredella; Martin Torriani; Elkan F Halpern; Daniel I Rosenthal; Dempsey S Springfield
Journal:  Skeletal Radiol       Date:  2015-09-04       Impact factor: 2.199

2.  Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma.

Authors:  Huan Zhao; Yong Wang; Min-Jie Wang; Zhi-Hui Zhang; Hai-Rui Wang; Bing Zhang; Hui-Qin Guo
Journal:  BMC Cancer       Date:  2017-04-28       Impact factor: 4.430

3.  Plasma miR-323 as a Biomarker for Screening Papillary Thyroid Cancer From Healthy Controls.

Authors:  Yang Liu; Lin Li; Zheng Liu; Qingling Yuan; Xiubo Lu
Journal:  Front Med (Lausanne)       Date:  2020-05-15

4.  Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma.

Authors:  Xiaojun Zhang; Xu Zhang; Wei Du; Liyuan Dai; Ruihua Luo; Qigen Fang; Hong Ge
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

5.  Improvement in the Detection of Cystic Metastatic Papillary Thyroid Carcinoma by Measurement of Thyroglobulin in Aspirated Fluid.

Authors:  Yong Wang; Huan Zhao; Yi-Xiang J Wang; Min-Jie Wang; Zhi-Hui Zhang; Li Zhang; Bin Zhang; Anil T Ahuja; Chun-Wu Zhou; Yu-Xin Jiang; Hui-Qin Guo
Journal:  Biomed Res Int       Date:  2016-01-04       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.